Massachusetts Financial Services’s Akebia Therapeutics AKBA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-226,786
| Closed | -$569K | – | 878 |
|
|
2020
Q3 | $569K | Sell |
226,786
-8,886
| -4% | -$22.3K | ﹤0.01% | 821 |
|
|
2020
Q2 | $3.2M | Sell |
235,672
-120,082
| -34% | -$1.63M | ﹤0.01% | 651 |
|
|
2020
Q1 | $2.7M | Buy |
355,754
+47,752
| +16% | +$362K | ﹤0.01% | 655 |
|
|
2019
Q4 | $1.95M | Sell |
308,002
-33,248
| -10% | -$210K | ﹤0.01% | 712 |
|
|
2019
Q3 | $1.34M | Buy |
341,250
+38,078
| +13% | +$149K | ﹤0.01% | 757 |
|
|
2019
Q2 | $1.47M | Buy |
303,172
+64,336
| +27% | +$311K | ﹤0.01% | 766 |
|
|
2019
Q1 | $1.96M | Buy |
+238,836
| New | +$1.96M | ﹤0.01% | 720 |
|
|
2018
Q3 | – | Sell |
-133,598
| Closed | -$1.33M | – | 852 |
|
|
2018
Q2 | $1.33M | Buy |
+133,598
| New | +$1.33M | ﹤0.01% | 751 |
|